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a b s t r a c t
The hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are expressed in pacemaker
cells very early during cardiogenesis. This work aimed at determining to what extent these channels are
implicated in the electromechanical disturbances induced by a transient oxygen lack which may occur
in utero.
Spontaneously beating hearts or isolated ventricles and outﬂow tracts dissected from 4-day-old chick
embryos were exposed to a selective inhibitor of HCN channels (ivabradine 0.1–10M) to establish
a dose–response relationship. The effects of ivabradine on electrocardiogram, excitation–contraction
coupling and contractility of hearts submitted to anoxia (30min) and reoxygenation (60min) were
also determined. The distribution of the predominant channel isoform, HCN4, was established in atria,
ventricle and outﬂow tract by immunoblotting.
Intrinsic beating rate of atria, ventricle and outﬂow tract was 164±22 (n=10), 78±24 (n=8) and
40±12bpm (n=23, mean± SD), respectively. In the whole heart, ivabradine (0.3M) slowed the ﬁring
rate of atria by 16% and stabilized PR interval. These effects persisted throughout anoxia-reoxygenation,
whereas the variations of QT duration, excitation–contraction coupling and contractility, as well as the
types and duration of arrhythmiaswere not altered. Ivabradine (10M) reduced the intrinsic rate of atria
and isolated ventricle by 27% and 52%, respectively, whereas it abolished activity of the isolated outﬂow
tract. Protein expression of HCN4 channels was higher in atria and ventricle than in the outﬂow tract.
Thus, HCN channels are speciﬁcally distributed and control ﬁnely atrial, ventricular and outﬂow tract
pacemakers as well as conduction in the embryonic heart under normoxia and throughout anoxia-
reoxygenation.
© 2010 Elsevier Ltd. All rights reserved.
1. Introduction
Hyperpolarization-activated cyclic nucleotide-gated (HCN)
channels are expressed in nodal, atrial and ventricular tissues, carry
the pacemaker funny current (If) and control the rate of diastolic
depolarization of the sinoatrial node in the adult heart [1,2]. Selec-
tive inhibition of these channels slows the cardiac rate [3] without
any effect on contractility [4] and can protect against ischemia-
induced myocardial injury [5–7]. HCN channels, including the pre-
dominant HCN4 isoform, are expressed very early during cardio-
genesis and are required for pacemaker activity [8–10]. Pacemaker
locus differentiates in the posterior segment of the primitive tubu-
lar heart [11,12] and strong If current can be generated by hyperpo-
larization in ventricular cardiomyocytes from the chick (3-day-old)
and the mouse (9.5-day-old) embryo [13–15], in contrast to adult
∗ Corresponding author. Tel.: +41 21 692 5526; fax: +41 21 692 5505.
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ventricular myocytes. Furthermore, hierarchy of intrinsic rhyth-
micity within the embryonic heart is illustrated by the fact that
dissected atria, ventricle and outﬂow tract beat spontaneously and
regularlyat their respectiveﬁring rate, i.e. atria > ventricle > outﬂow
tract [16]. This observation suggests thatmembrane density and/or
properties of the HCN channels, besides non-HCN pacing mecha-
nisms, might vary from one cardiac region to another.
Throughout the embryonic and fetal life, occasional transient or
prolonged reduction in oxygen availability can lead to reversible
or irreversible cardiac arrhythmias, threatening fetal growth. The
mechanisms underlying hypoxia-induced rhythm abnormalities
in the developing heart remain poorly understood and deserve
to be investigated. We have previously shown that anoxia and
reoxygenation induce rapid and severe electrical and mechani-
cal disturbances in the 4–5-day-old embryonic chick heart model
[16,17]. Arrhythmic activity of isolated atria persists through-
out anoxia and upon reoxygenation, whereas activity of isolated
ventricles rapidly ceasesunderanoxiaand resumes lateafter reoxy-
genation.Whether HCN channels are involved in such disturbances
1043-6618/$ – see front matter © 2010 Elsevier Ltd. All rights reserved.
doi:10.1016/j.phrs.2009.09.007
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and whether their inhibition has beneﬁcial consequences, as in the
adult heart, remains to be explored.
This study mainly aimed at examining the contribution of the
HCN channels to pacemaker activity and conduction in the embry-
onic heart as well as investigating their role in cardiac dysfunction
induced by anoxia and reoxygenation.
2. Material and methods
2.1. Reagents
Standard chemicalswere purchased fromSigma (SigmaAldrich,
Buchs, Switzerland). The speciﬁc inhibitor of HCN channels ivabra-
dine was kindly provided by Servier (France).
2.2. Preparation and in vitro mounting of the heart
Fertilized eggs from Lohman Brown hens were incubated dur-
ing 96h at 38 ◦C and 95% relative humidity to obtain stage 24HH
embryos (according toHamburger andHamilton [18]). Heartswere
carefully excised from embryos and dissected in order to iso-
late ventricles and outﬂow tracts. Spontaneously beating hearts
or the isolated parts were placed in the culture compartment of
a stainless steel airtight chamber. Such device was equipped with
two windows for observation as well as measurements and main-
tained under controlled conditions on the thermostabilized stage
(37.5 ◦C) of an inverted microscope (IMT2 Olympus, Tokyo, Japan)
as previously described in detail [17]. Brieﬂy, the culture com-
partment (300l) was separated from the gas compartment by
a 15m transparent and gas-permeable silicone membrane (RTV
141, Rhône-Poulenc, Lyon, France). Hearts, ventricles and outﬂow
tracts were slightly ﬂattened by the silicone membrane and the
resulting thickness of the myocardial tissue facing the gas com-
partment was approximately 300m. Thus, pO2 at the tissue level
could be strictly controlled and rapidly modiﬁed (within less than
5 s) by ﬂushing high-grade gas of selected composition through the
gas compartment.At thisdevelopmental stage, theheart lacks coro-
naryvascularizationand themyocardial oxygen requirement ismet
exclusively by diffusion.
The HCO3/CO2 buffered medium was composed of (in mM):
99.25 NaCl; 0.3 NaH2PO4; 10 NaHCO3; 4 KCl; 0.79 MgCl2; 0.75
CaCl2; 8 d(+)glucose. This culture medium was equilibrated in the
chamber with 2.31% CO2 in air (normoxia and reoxygenation) or in
N2 (anoxia) yielding a pH of 7.4. Ivabradine was dissolved in the
culture medium just before experiments.
2.3. Recording of electrical and contractile activity
Electrical and contractile activities were recorded simulta-
neously and continuously throughout in vitro experiments as
previously described [16].
2.3.1. Electrical activity
ECG recordings of the spontaneously contracting intact hearts
were performed using twoAg/AgCl electrodes 1.2mmapart (diam-
eter 0.625mm) inserted into the window facing the culture
compartment. The atrial and ventricular regions of the heart were
placed in the immediate vicinity of these electrodes, which were
connected to a differential preampliﬁer (gain of 2000), result-
ing in an output signal of 1–5V peak to peak. This signal was
digitized and processed using a powerful data acquisition (IOX,
sampling rate: 2 kHz) and analysis system (ECG-Auto) developed
by EMKA Technologies (France). ECG displayed characteristic P,
QRS and T components, which allowed to assess the beating rate
from RR interval (beats/min, bpm), PR interval (ms) and QT dura-
tion (ms). CorrectedQT (QTc)was calculated using Bazett’s formula
(QT/RR1/2).
2.3.2. Contractile activity
Adjustable phototransistors were positioned over the projected
imageof the investigated regionsallowingdetectionof edgemotion
of the myocardial wall, i.e. at the level of atrial pacemaker and
ventricular apex of the intact heart. Simultaneously with ECG,
myocardial shortening was sampled at a rate of 1 kHz using the
same acquisition/analysis system as described above. The actual
ventricular shortening at the apex (m) was determined using
video recordings performed just before anoxia and at the end of
reoxygenation.
2.3.3. Excitation–contraction coupling
The electromechanical delay (EMD,ms), reﬂecting the efﬁciency
of excitation–contraction (E–C) coupling, was determined at the
level of the right atrium and at the apex of the ventricle by mea-
suring the delay between the very initial phase of the P and QRS
components and the initiation of contraction in atrium and ventri-
cle, respectively, as previously described [16].
2.4. Experimental protocols
2.4.1. Dose–response curve
Whole hearts, isolated ventricles and outﬂow tracts were
pretreated with ivabradine at room temperature during 30min,
mounted in the culture chamber and exposed to normoxia dur-
ing 1h in the absence (control) or the presence of ivabradine. The
tested concentrations of ivabradine ranged from 0.1 to 10M. The
spontaneous beating rate was determined at the end of the proto-
col.
2.4.2. Anoxia-reoxygenation protocol
Whole hearts (pretreated or not with 0.3M ivabradine) were
placed in the chamber, stabilized during 45min under normoxia
and submitted to anoxia (30min) followed by reoxygenation
(60min). Ivabradine (0.3M) was present throughout anoxia-
reoxygenation and electrical (ECG) as well as contractile activities
were continuously recorded.
2.5. Western Blotting of HCN4 channels
A total of 84 hearts have been used and carefully dissected
into atria, ventricle and outﬂow tract. Six atria, 3 ventricles and
6 outﬂow tracts were pooled for each sample preparation. Pro-
tein extracts were generated from the dissected regions using a
lysis buffer (in mM: 20 Tris-acetate (pH 7), 270 sucrose, 1 EGTA,
1 EDTA, 50 NaF, 10 -glycerophosphate, 10 dithiothreitol (DTT),
10 4-nitrophenyl phosphate disodium salt hexahydrate (PNPP), 1%
Triton X-100 and inhibitors of proteases). Insoluble material was
removed by a 5min centrifugation at 10,000g. Protein concen-
tration was determined by the Bradford method. Samples were
denatured in sample buffer (6min, 95 ◦C), 20g of protein were
loaded per lane, separated on 10% SDS-polyacrylamide gels, and
transferred tonitrocellulosemembranes.Membraneswereblocked
(overnight at 4 ◦C) with 5% non-fat milk in PBS and probed (2h
at room temperature) with rabbit polyclonal antibody against
HCN4 1:200 (Alomone Labs, Jerusalem, Israel) or GAPDH 1:1000
(Abcam, Cambridge, UK). A control fusion protein was used as
control antigen. Anti-HCN4 antibody was preincubated with the
antigen (for negative control) into PBS–5% non-fat dry milk for 1h.
After 4 washes in 0.1% Tween 20 PBS the membranes were incu-
bated in 1:10,000 dilution of horseradish peroxidase-conjugated
anti-rabbit IgG (Amersham Biosciences) in PBS containing 5%
non-fat milk (1h, room temperature) and then washed 4 times.
Author's personal copy
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Immunoreactive bands were detected with enhanced chemilumi-
nescent procedure using ECL Western Blotting Analysis System
(Amersham Biosciences). Autoradiograms were scanned and den-
sitometric analysisperformedwithQuantityOnesoftware (Biorad).
Protein bands were normalized using GAPDH in the same sample
as reference.
2.6. Statistical analysis
All values are reported as mean± standard error of the mean
(SEM) unless otherwise indicated. The signiﬁcance of any differ-
ence between two groups was assessed with Student t-test or
repeated measures ANOVA (to compare rates of recovery), while
differences in the dose–response of ivabradine were determined
using one-way ANOVA completed by Tukey’s post hoc test using
SPSS software. Mann–Whitney test was used to compare slopes of
the PR–RR relationship. The statistical signiﬁcance was deﬁned by
a value of p<0.05.
3. Results
3.1. HCN4 channels are differentially expressed within the
embryonic chick heart
Immunoblotting shows that expression of the predominant iso-
form HCN4 was higher in atria and ventricle than in the outﬂow
tract of the embryonic chick heart (Fig. 1). The speciﬁcity of the
Fig. 1. Representative immunoblot of the HCN4 channel and GAPDH (upper panel)
and quantitative densitometry of HCN4 corrected for GAPDH (lower panel) showing
that HCN4 was inhomogeneously distributed in the embryonic chick heart at stage
24HH. Bars represent the mean± SEM from 14, 12 and 11 independent determina-
tions for atria, ventricle and outﬂow tract, respectively.
anti-HCN4 antibody was controlled by immunoblotting with the
anti-HCN4 antibody preincubated with the corresponding anti-
gen. The band normally found at about 160kDa, corresponding to
HCN4, disappeared completely in the presence of the antigen (not
shown).
3.2. Dose–response curve for ivabradine was different in atria,
ventricle and outﬂow tract
In vitro, all atria (in whole hearts) and dissected ventricles beat
at their intrinsic rate, whereas only about 25% of the dissected
outﬂow tracts beat spontaneously and regularly. Under normoxia,
the intrinsic beating rate of the untreated atria, isolated ventri-
cles and outﬂow tract was 164±22 (n=10), 78±24 (n=8) and
40±12 bpm (n=23, mean± SD), respectively, and remained sta-
ble in vitro. The dose–response curves (Fig. 2) show that inhibition
of HCN channels by 1M ivabradine signiﬁcantly (p<0.01) slowed
the ﬁring rate of atria (dropping to 134±17bpm, n=6) and ven-
tricle (dropping to 39±19bpm, n=7) respectively. The highest
concentration of ivabradine (10M) further decreased moderately
atrial rate, had no additional effect on ventricular rhythm but com-
pletely stopped spontaneous activity of the outﬂow tract (Fig. 2).
Thus, the maximal inhibitory effect of ivabradine is achieved at
0.3–1 and 10M in ventricle and outﬂow tract, respectively. Since
the ventricular rate was already altered at a low concentration of
ivabradine (0.3M), we investigated the functional consequences
of HCN inhibition during anoxia-reoxygenation at this concentra-
tion only.
Fig. 2. Dose–response curves of whole hearts (black diamonds), dissected ventri-
cles (open circles) and outﬂow tracts (open squares) treated with ivabradine under
normoxia. The spontaneous beating rate of atria, isolated ventricles and outﬂow
tracts was expressed as raw data (A) or as percent of the respective control value
representing ivabradine efﬁciency (B). Control: untreated preparation; broken lines
indicate the control level; bpm: beats per min.; mean± SEM; n=4–11 for atria and
ventricle; n=9–23 for outﬂow tract; *: p<0.01 dissected ventricle or outﬂow tract
versus atria in whole heart; $: p<0.01 outﬂow tract versus ventricle; #: p<0.01
versus respective control.
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Fig. 3. Representative ECGs illustrating the P, QRS and T components of the embry-
onic chick heart spontaneously beating in vitro under normoxia and showing how
RR, PR and QT intervals have been analysed in control and ivabradine (0.3M)
treated hearts.
3.3. Inhibition of HCN channels had a bradycardic effect
associated with a stabilization of conduction without affecting the
pattern of arrhythmias throughout anoxia-reoxygenation
Under preanoxic conditions, ivabradine (0.3M) reduced atrial
rate and PR interval by 20%, but did not alter QT duration, ven-
tricular EMD and ventricular shortening (Figs. 3 and 4). It should
be noticed that the preanoxic atrial rate of untreated hearts
(186±9bpm, n=5, Fig. 4) was slightly higher than heart rate
of the controls of the dose–response experiments (164±7bpm,
n=10, Fig. 2) although it did not reach statistical signiﬁcance.
Such a difference between the two series of experiments, com-
bined with a higher coefﬁcient of variability of atrial rate at 0.3M
ivabradine in Fig. 2 (18%; n=5) than that in Fig. 4 (12%; n=5),
could explain that the bradycardic effect of 0.3M ivabradine
on atria was signiﬁcant during preanoxia (p=0.03) but not under
the conditions of the dose–response determination (p=0.09). As
we recently described [16], anoxia induced bradycardia, atrial
ectopy, 1st, 2nd and 3rd degree A-V blocks as well as transient
arrests followed by bursting activity. Reoxygenation triggered also
Wenckebach phenomenon and ventricular escape beats. All hearts
fully recovered after 30–50min of reoxygenation. Relative to con-
trol after 10min anoxia, ivabradine augmented the mean atrial
rate measured during bursts of activity with no effect on other
functional parameters (Fig. 4). During reoxygenation, ivabradine
shortened PR interval with respect to untreated hearts. Neverthe-
less, the types, incidence and duration of arrhythmias were not
signiﬁcantly affected by ivabradine (Table 1). Relative to control,
ivabradine did not alter QTc neither under normoxia (0.25±0.02
and 0.28±0.03 s, in control and treated group, respectively, n=5)
nor throughout reoxygenation (peaking after 9min of reoxygena-
tion at 0.35±0.07 and 0.30±0.02 s in control and ivabradine,
respectively). However, the mean of all the QTcs which were
possible to determine, i.e. in the absence of AV blocks, at 11,
13, 20, 25 and 30min of anoxia (see Fig. 4), was longer in the
ivabradine group (0.28±0.06 s, n=17) than in the control group
(0.23±0.04 s, n=16;± SD) (p=0.006). Furthermore, as previously
described [19], atrial EMD was longer than ventricular EMD under
baseline condition (i.e. 19.9±0.9ms vs 12.1±1.8ms) and was
not signiﬁcantly affected by reoxygenation and ivabradine (not
shown). Ta
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Fig. 4. In thewhole heart, ivabradine decreased atrial rate and shortened PR interval
under normoxia (preanoxia) and throughout reoxygenation. By contrast, QT dura-
tion, ventricular electromechanical delay (EMDv) and ventricular shortening were
not affected. Mean± SEM; n=5 for each condition; *: p<0.05 versus control.
3.4. Correlation between heart rate and atrio-ventricular
conduction
Fig. 5 clearly shows that atrio-ventricular conductionunder nor-
moxia depended on beating rate since the longer the RR interval,
the shorter the PR interval, regardless if ivabradine was applied or
not. Furthermore, a beat-to-beat analysis performed in individual
hearts revealed that speciﬁc inhibition of HCN channels by ivabra-
dine stabilized conduction, specially when RR varied between 370
and 475ms, i.e. between 160 and 130bpm. Indeed, the individual
slope PR/RR (250 data points per heart) was signiﬁcantly higher in
the control group (0.53±0.27, n=5) than in the ivabradine treated
group (0.10±0.04, n=5) (p=0.032). However, during anoxia and
reoxygenation no signiﬁcant correlation could be properly estab-
Fig. 5. Beat-to-beat analysis performed in individual hearts showing that the rela-
tionship between PR interval and RR interval under normoxic conditions is different
in control and ivabradine treated hearts, the PR interval being stabilized by ivabra-
dine. The general linear relationship between PR interval and RR interval is shown
in the inset regardless if ivabradine was applied or not (r2 = 0.62). Each beat-to-
beat analysiswas performedon250 successive preanoxic cardiac cycles; Ivabradine,
0.3M; r2: coefﬁcient of determination of the linear regression; n=5 hearts in each
group.
lished between PR and RR intervals, most likely due to major
electromechanical disturbances, including numerous AV blocks
(see Table 1).
4. Discussion
4.1. Dose–response curve for ivabradine
The inhibition of the If current by ivabradine is known to be
speciﬁc, selective and use-dependent at concentrations lower than
10M. However, at higher concentrations unspeciﬁc currents,
such as calcium currents (L and T type) that play an important
functional role in the embryonic heart, are also inhibited [3]. For
this reason, dose–response curves have been determined within
the range of 0.1–10M of ivabradine. Interestingly, ivabradine
lowered embryonic atrial rate in the very same range of concen-
trations (1–3M) and to the same extent (∼20%) than in adult
sinoatrial node cells [4,20], corresponding to half-block concen-
trations for HCN1 and HCN4 subtypes [20,21]. These observations
indicate that the pharmacological modulation of HCN channels
could be similar in embryonic and adult pacemaker cells, which
deserves to be further investigated. Although ivabradine (1M)
decreased the beating rate by about 40bpm both in atria and ven-
tricle (equal effect), it was more efﬁcient in ventricle than in atria,
i.e. a drop of frequency of 50% versus 20%. Furthermore, compared
with other regions, ivabradine had a stronger inhibitory effect on
spontaneous activity of the outﬂow tract, even at the lowest con-
centration.
Concentrations of ivabradine higher than 0.3M decreased
further atrial rate but had no additional effect on ventricular
rhythm, suggesting that non-HCN pacing mechanisms, such as
sodium–calcium exchanger [22] and intracellular calcium release
[23,24], can also contribute topacemaker currentmoremarkedly in
the ventricle than in atria of the embryonic heart. Our experiments
showing that spontaneous contractionsof the isolatedoutﬂowtract
were totally abolished by ivabradine, in contrast to atria and ven-
tricle, support the hypothesis that pacemaking activity in this part
of the heart rely onHCN channels exclusively, and including at least
HCN4.
Under normoxia, ivabradine had a negative chronotropic effect
without any inotropic effect, alike in adult sinoatrial myocytes
[4]. Thus, the fact that inhibition of HCN channels slowed the
Author's personal copy
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spontaneous beating rate differently in the three cardiac regions
and that the HCN4 isoform was inhomogenously distributed,
suggest a subtle gradient of density and/or properties of HCN
channels along the developing heart.
4.2. Anoxia-reoxygenation
The embryonic heart at the investigated stage is not innervated
by the autonomic nervous system and no neurohumoral inﬂuence
exists under our in vitro conditions. Thus, the observed changes
of pacemaker rate during anoxia-reoxygenation were exclusively
regulated at the cardiomyocytes level.
In addition to its negative chronotropic effect, inhibition of HCN
channels appears to stabilize atrio-ventricular conduction, espe-
cially when heart rate is below 160bpm, under normoxia (Fig. 5)
as well as during anoxia and reoxygenation (Fig. 4). To our knowl-
edge, such a dromotropic effect of HCN channel inhibition has not
been reported in adult heart [5,25]. It should be noticed that this PR
interval stabilizing effect can be clearly observed with ivabradine,
but it may not be exclusively due to HCN inhibition.
It has been shown [26] that if HCN channels are blocked, cells
tend to hyperpolarize more which in turn relieves inactivation of
more Ca2+ and/or Na+ channels involved in action potential prop-
agation and consequently improves conduction. This hypothesis is
strongly supported by the evident correlation observed between
PR interval and RR interval. A complementary interpretation is
that Ca2+ reuptake into sarcoplasmic reticulum and transsarcolem-
mal Ca2+ extrusion, taking place during a signiﬁcantly prolonged
diastole (+25%), could somewhat lower basal diastolic intracellular
calcium relative to untreated hearts. This is consistent with a slight
enhancement of gap junction permeability by a lower intracellular
Ca2+. Indeed, although there is no specialized conduction system at
the stage investigated, various connexins (e.g. Cx43) forming gap
junctions are expressed and functional during early cardiogene-
sis [27,28]. Furthermore, alike in adult heart, decreasing heart rate
reduces myocardial oxygen consumption in the embryonic chick
heart at stage 24HH [29], which is known to protect heart func-
tion especially during an ischemic/hypoxic episode. Remarkably,
during anoxia and reoxygenation, inhibition of HCN channels did
not affect ventricular depolarization–repolarization (QT duration),
excitation–contraction coupling (EMD) and contractility (shorten-
ing) and had no additional proarrhythmic effects as those observed
in the adult mouse heart model at highly unspeciﬁc ivabradine
concentrations [30]. During the last 20min of anoxia QTc was
23% longer in ivabradine treated hearts than in control hearts but
no additional arrhythmias were observed. Although a longer QTc
puts an adult heart at increased risk for arrhythmias, it does not
seem to be the case in the minute embryonic heart at stage 24HH
in which the compact myocardium of the ventricle is very thin
(200–300m)andactionpotential durationquiteuniforminspace.
Although a tendency toward a shorter time to resumption in
atria and ventricle of treated hearts relative to control hearts can
be observed in Table 1, there was no signiﬁcant difference between
the experimental groups. It should be noticed that the relatively
important interindividual variability of the investigated parame-
ters is probably due to slight differences in developmental stage,
level of differentiation, cardiac dimensions and degree of ﬂattening
of the hearts in the culture compartment as previously discussed
[17]. Moreover, the unavoidable arrhythmic activity induced by
anoxia and reoxygenation was also responsible for a great variabil-
ity. For example, in Fig. 4, the fact that atrial rate during anoxia was
the average rate determined during bursts of activity contributed
to increase interindividual variability. Nevertheless, the preanoxic
PR andQT valueswerewithin the range found in our previouswork
[16].
4.3. Distribution of the HCN4 channel
The antibody against HCN4 identiﬁed a band at about 160kDa,
corresponding to molecular weight of HCN4 which predominates
over the other HCN isoforms in the adult sinoatrial node [31].
Our data provide the ﬁrst direct evidence that the HCN4 channel,
considered as the predominant isoform during early cardiogen-
esis [8–10], is inhomogeneously distributed within the heart of
the chick embryo, i.e. atria = ventricle > outﬂow tract. Ivabradine at
10M reduced the beating rate in both atria and ventricle by about
40bpm but abolished spontaneous activity of the outﬂow tract.
These ﬁndings support the concept that the low intrinsic beating
rateof theoutﬂowtract canbeattributed to the lowdensityofHCN4
channels. As the fate of the outﬂow tract is to differentiate at older
stages into aorta and pulmonary artery rather than spontaneously
contracting myocardium, it is not surprising that this otherwise
slowly conducting region exhibited the lowest HCN4 expression.
The possibility that other subtypes of HCN channels (i.e. HCN1,
2) blocked by ivabradine and known to be present in the adult heart
[2], are expressed in the embryonic heart and play a role in atrial
and ventricular pacemaking cannot be ruled out. Furthermore, the
spatial distribution ofHCN4drastically changes throughout cardiac
development [8,32] andHCN4canheteromerizewithHCN2 to form
functional pacemaker channels in the embryonic heart [33].
5. Conclusion
Thegradient of intrinsic beating ratewithin the embryonicheart
model, the differential efﬁciency of ivabradine in the sinoatrial
region, ventricle and outﬂow tract and the characteristic distribu-
tionof thepredominantHCN4 isoformalong theheart, indicate that
HCN channels play an important role in the ﬁne control of the rate
of diastolic depolarization in all cardiac regions.Moreover, ourﬁnd-
ings show that HCN channels can be involved in the chrono- and
dromotropic responses to transient oxygen deprivation without
affecting E–C coupling or contractility.
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